AJP - Regulatory, Integrative and Comparative Physiology, Vol 261, Issue 4 858-R864, Copyright © 1991 by American Physiological Society

ARTICLES

Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure

Z. Abassi, J. C. Burnett Jr, E. Grushka, A. Hoffman, A. Haramati and J. Winaver
Rappaport Institute for Research in the Medical Sciences, Faculty of Medicine, Technion, Haifa, Israel.

Rats with chronic aortocaval (AV) fistula, an experimental model of congestive heart failure, display high plasma levels of atrial natriuretic factor (ANF) and a blunted natriuretic response to ANF infusion. We previously reported that rats with AV fistula either develop progressive sodium retention (urinary sodium excretion, UNaV less than 100 microeq/24 h) or compensate (UNaV greater than 1,200 microeq/24 h). To gain further insight into the mechanism of renal hyporesponsiveness to ANF, we evaluated the effect of ANF on renal guanosine 3',5'-cyclic monophosphate (cGMP) production in sham-operated control rats and in the two groups of rats with AV fistula. Infusion of synthetic ANF-(99-126) (at either 10 or 50 micrograms.kg-1.h-1) resulted in a reduced fractional sodium excretion (P less than 0.05) in both compensated rats (0.7 +/- 0.2 and 7.9 +/- 1.6%) and sodium-retaining rats (0.3 +/- 0.1 and 0.5 +/- 0.1%) compared with controls (8.5 +/- 1.2 and 13.7 +/- 2.3% for low and high doses, respectively). Similarly, urinary cGMP excretion corrected by glomerular filtration rate (UcGMPV/GFR) during low-dose ANF infusion was significantly reduced (P less than 0.05) in both groups with AV fistula (compensated: 39 +/- 10 pmol/ml; sodium-retaining: 55 +/- 13 pmol/ml) compared with controls (115 +/- 16 pmol/ml). During high-dose ANF infusion, compensated rats, but not sodium-retaining rats, displayed a significant increase in UcGMPV/GFR. The differences in UcGMPV/GFR are probably not due to variations in urine flow because furosemide infusion to a separate group of rats with AV fistula increased urine flow approximately eightfold but did not increase UcGMPV/GFR.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				P. M. Bryan, X. Xu, D. M. Dickey, Y. Chen, and L. R. Potter Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1636 - F1644. [Abstract] [Full Text] [PDF]

				T. H. Langenickel, I. Pagel, J. Buttgereit, K. Tenner, M. Lindner, R. Dietz, R. Willenbrock, and M. Bader Rat corin gene: molecular cloning and reduced expression in experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1516 - H1521. [Abstract] [Full Text] [PDF]

				G. M. Bialik, Z. A. Abassi, I. Hammel, J. Winaver, and D. Lewinson Evaluation of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Atrial Granules of Rats with Experimental Congestive Heart Failure J. Histochem. Cytochem., October 1, 2001; 49(10): 1293 - 1300. [Abstract] [Full Text] [PDF]

				Z. A. Abassi, K. Gurbanov, S. E. Mulroney, C. Potlog, T. J. Opgenorth, A. Hoffman, A. Haramati, and J. Winaver Impaired Nitric Oxide–Mediated Renal Vasodilation in Rats With Experimental Heart Failure : Role of Angiotensin II Circulation, November 18, 1997; 96(10): 3655 - 3664. [Abstract] [Full Text]

				F. Pieruzzi, Z. A. Abassi, and H. R. Keiser Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure Circulation, November 15, 1995; 92(10): 3105 - 3112. [Abstract] [Full Text]

				Z. A. Abassi, S. Kotob, E. Golomb, F. Pieruzzi, and H. R. Keiser Pulmonary and Renal Neutral Endopeptidase EC 3.4.24.11 in Rats With Experimental Heart Failure Hypertension, June 1, 1995; 25(6): 1178 - 1184. [Abstract] [Full Text]